Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 259, Issue 1-2, Pages 74-78Publisher
ELSEVIER
DOI: 10.1016/j.jns.2006.05.073
Keywords
multiple sclerosis; immunosuppression; clinical trials; corticosteroids; azathioprine; mitoxantrone; cyclophosphamide; metotrexate
Categories
Ask authors/readers for more resources
The author participated very early in the use of immunosuppressors in the treatment of multiple sclerosis. He reviews evidence which support their use. IV Methylprednisolone, azathioprine and mitoxantrone are supported in their use by evidence of a level appropriate to the date of their generation while Cyclosporine A and Cyclophosphamide are not. The author also reviews the benefits and side effects of each of these medications, insisting on a practical approach to their use. The author concludes that since immunomodulators have been approved, the use of the irnmunosuppressors has been reduced, however there is a strong possibility that their use will be rekindled in association with immunomodulatory medications. (C) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available